I spoke with Dr. Bateman's research team yesterday and they are considering re-starting the 511 trial (where you pay for everything, ~20k/year) for ampligen. A big factor in their decision is having enough patients in the trial to make it cost-effective from an administrative standpoint. They said they probably won't start before 2011. I confirmed this with the clinical trial rep at Hemispherx, who says things may move along even quicker than that once they agree on the contract. I would advise anyone who is interested to contact Dr. Bateman's research team.